For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived.
First on Tuesday, Geoffrey Hinton and John Hopfield won the physics prize for their pioneering work in creating the foundations of modern AI.
Then on Wednesday, David Baker, John Jumper and Demis Hassabis shared the chemistry prize for work revealing the secrets of proteins through AI.
While the trio had been among the favorites for the chemistry prize, the physics one was unexpected.
“I’m flabbergasted,” said Hinton when he was told of the prize. “I had no idea this would happen. I’m very surprised.”
He wasn’t the only one.
Online commentators wondered why a computer scientist was getting a physics prize.
And with programs such as OpenAI’s ChatGPT dominating the cultural conversation around AI, for many the idea that such a technology could be worthy of such an award seemed bizarre.
‘AI winter’
But for scientists the news was not so surprising.
“AI’s role in transforming how we do science cannot be underestimated,” Elena Simperl, a professor at King’s College London’s informatics department, told AFP.
“The Nobel prize news recognizes this, while also acknowledging the role interdisciplinary methods play in advancing computing.”
The science now bundled together as artificial intelligence has a long history, emerging in the 1950s and 60s with rudimentary chatbots, translation machines and simple algorithms.
But many of the early experiments failed to take off and researchers struggled to get funding, particularly during the 1970s and the 1990s, periods known as “AI winters”.
Before the latest explosion of interest prompted by ChatGPT in 2022, AI had only had a handful of moments when it pierced the public imagination.

In 2016, a program called AlphaGo created by Hassabis’s DeepMind beat South Korean grandmaster Lee Se-Dol at the game Go.
It came almost a decade after the IBM-developed supercomputer Deep Blue beat world chess champion Garry Kasparov.
In his acceptance speech, Hassabis flagged that there was a direct line between AlphaGo and AlphaFold, the program that won them the Nobel for predicting protein structures.
“We used games in the early part of DeepMind to train as a proving ground for our early algorithms that then led to some of the techniques we eventually use in our modern programs,” he said.
And he encouraged children to play games, saying it was “just a really fun way to get into the guts of how computers work”.
New Nobels needed?
Simperl said that, far from it being problematic to see AI pioneers being rewarded by the Nobels, it should be encouraged.
“Maybe it’s time for this to be recognized with a new Nobel prize category,” she said.
She added that disciplines like software engineering and cybersecurity also deserved recognition for their contributions to society.
“There is no issue in my mind with an AI scientist being recognized in a Nobel prize scientific category,” she said.
“This is merely an acknowledgement of how modern science works today.”
Outside the science community, the conversation continues to be dominated by the astronomical valuations of AI companies and the outsize cultural influence of some of their leaders.
After Wednesday’s prize was announced, online memes quickly emerged suggesting Sam Altman, boss of ChatGPT-maker OpenAI, could be next in line.
“It’s not done yet,” Sean O’Heigeartaigh, director of the AI: Futures and Responsibility Program at the University of Cambridge, wrote on the social media platform X.
“Hearing reports that the Nobel prize for literature will be going to the authors of ‘OpenAI’s nonprofit governance structure’ for outstanding contributions to creative fiction.”
© 2024 AFP
News
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]















